source
- Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sAbout 20,000 people are taking Eli Lilly’s obesity pill Foundayo after its first 20 days on the market, according to the company’s CEO David Ricks. This points to a markedly slower launch of the dr…Endpoints · 3mo ago↗ source
- The R&D 15: How pharma's top companies spent, won and lost on drug researchTalking over pharma pipelines with a major drugmaker's development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final one on the list brought in about $4 billion last ...Endpoints · 3mo ago↗ source
- Novartis unveils North Carolina factory as final new build in $23B US expansionNovartis on Thursday revealed its plans to build another factory in the US, with the Swiss drugmaker noting that it has now allocated every dollar of its $23 billion promise to expand ...